Navigation Links
Innovative Clinical Solutions, Ltd. Announces Second and Final Liquidating Cash Distribution
Date:12/13/2010

PHILADELPHIA, Dec. 13, 2010 /PRNewswire-FirstCall/ -- Innovative Clinical Solutions, Ltd. (Pink Sheets: ICSN) has announced that, in accordance with its plan of liquidation approved by its shareholders on September 22, 2007, its sole Director has approved a second and final liquidating cash distribution (the "Final Liquidating Distribution") in the amount of $0.039251 per share of its outstanding common stock.  The Final Liquidating Distribution will have a record date of December 9, 2010, a payment date of December 16, 2010, and an ex-dividend date of December 17, 2010.  The stock transfer books of the Company will be closed as of December 16, 2010.  The Company will make no further distributions beyond the Final Liquidating Distribution.  There is no requirement for stockholders to surrender shares in connection with the Final Liquidating Distribution.  

An "ex-dividend date" is the date on which a security is traded without a previously declared dividend or distribution.  The timing of the Company's ex-dividend date is determined in accordance with the FINRA rule applicable to such distributions, because the amount of the distribution exceeds 25% of the Company's share value.  Between the record date of December 9, 2010, and the ex-dividend date of December 17, 2010, the stock will trade with due bills reflecting the seller's obligation to transfer the distribution to the buyer.  The due bill redeemable date is December 21, 2010.  

Upon payment of the Final Liquidating Distribution, the Company will have made liquidating distributions (including the first partial liquidating cash distribution made on June 30, 2008, and the Final Liquidating Distribution) in the aggregate amount of $2,990,755, or $0.249251 per share of the Company's common stock.  

Safe Harbor

This press release may contain forward-looking statements within the meaning of the federal securities laws, including statements regarding the timing and amounts available for distributions to holders of the Company's common stock.  Such statements reflect the Company's current expectations with respect to future events and are based on its current assumptions and information currently available.  Actual results may differ materially.  There can be no assurance that the Company's expectations will be achieved.  These forward looking statements are neither promises nor guarantees.  The Company undertakes no responsibility to revise or update and such forward-looking statements.  


'/>"/>
SOURCE Innovative Clinical Solutions, Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. ActiveHealth Management to Deliver Innovative NuVal™ Nutritional Scoring System Through Health Website
2. Chilean Companies Show Innovative Solutions
3. Top Business School Students From Around the World Compete for Innovative Solutions to the Global Clean Water Crisis
4. FDA Launches Initiative to Develop Innovative External Defibrillators
5. Argos Therapeutics to Present Potential of its Arcelis™ Immunotherapy as an Innovative, Effective Treatment for HIV at the APHA 138th Annual Meeting & Exposition
6. NxStage® Expands Product Portfolio With Innovative Patient Access Surveillance Solution From Vasc-Alert™
7. New England Biolabs Launches a Suite of Innovative Tools to Advance Epigenetics Research, Including PCR-Based Assay to Identify and Quantitate 5-hmC in Epigenome
8. CVS Caremark Research Highlights How Innovative Plan Designs Help Clients Reduce Drug Spend and Improve Generic Dispensing Rates
9. Physicians Pharmaceutical Corporation Offers Innovative On-Site Drug Dispensaries
10. Results of Innovative Clinical Study Show New Combination for Weight Loss Success
11. AT&T and eCardio Diagnostics Team Up to Advance Cardiac Care Through Innovative Mobile Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... , March 29, 2017 On March 28, the ... treat adult patients with relapsing forms of multiple sclerosis ... the first drug approved by the FDA for PPMS. ... care professional.  "Multiple sclerosis can have ... Billy Dunn , M.D., director of the Division of ...
(Date:3/29/2017)... FinancialBuzz.com News Commentary  ... Data published in a research report by Grand View Research, ... of USD 55.8 billion by 2025. The projection takes into consideration the ... and a more open approach towards cannabis products around the world. In ... , North Dakota , Ohio , ...
(Date:3/29/2017)... , March 29, 2017 FinancialBuzz.com News ... The U.S. ... According to a new report published by New Frontier Data, the ... The accelerating pace of cannabis legalization in the United ... cannabis, are considered to be a major factor that drives growth ...
Breaking Medicine Technology:
(Date:3/29/2017)... ... 2017 , ... Based on research from Guardian’s Fourth Annual ... trying to balance both short-term and long-term benefits demands. Are employers struggling ... complexity, companies are finding that the short-term strategies used to control costs, improve ...
(Date:3/29/2017)... Chicago, Illinois (PRWEB) , ... March 29, 2017 ... ... Visio Stencils Device Library for documenting and diagramming network and data center assets ... , NetZoom subscribers can request new equipment shapes for free and download ...
(Date:3/29/2017)... ... , ... Immunotherapy has emerged as one of the most promising options for ... the next revolution in our fight against this complex disease. One of the most ... inhibitors such as PD-1 and PD-L1 inhibitors. , While a few single analyte immunohistochemistry ...
(Date:3/29/2017)... ... ... AvePoint , the Microsoft Cloud expert, is pleased to announce the ... the Riverfront Plaza, 901 East Byrd Street. AvePoint is celebrating with a ribbon-cutting ceremony ... Mayor of Richmond Levar M. Stoney. , Founded in 2001, AvePoint employs more than ...
(Date:3/28/2017)... ... March 28, 2017 , ... India’s Chigurupati Technologies ... directly address the resolution to globally reduce the harmful use of alcohol set ... FDA and TTB approved ingredients that when infused into alcohol, renders the alcohol ...
Breaking Medicine News(10 mins):